�鶹ԭ��

1. Executive Summary
2. Research Methodology
3. Neurovascular �鶹ԭ��
3.1 Introduction
3.1.1 Background
3.1.2 Neurovascular Devices
3.2 �鶹ԭ�� Analysis
3.2.1 �鶹ԭ�� Sizing (Actual & Forecasted)
3.2.2 �鶹ԭ�� Share by Region
3.2.3 �鶹ԭ�� Share by Therapeutic Application
3.2.4 �鶹ԭ�� Share by Technique
4. Global Neurovascular �鶹ԭ�� Segmentation
4.1 Cerebral Thrombectomy Devices
4.1.1 Overview
4.1.2 �鶹ԭ�� Sizing (Actual & Forecasted)
4.1.3 �鶹ԭ�� Share by Region
4.2 Flow Diverter for Aneurysm
4.2.1 Overview
4.2.2 �鶹ԭ�� Sizing (Actual & Forecasted)
4.2.3 �鶹ԭ�� Share by Region
4.3 Carotid Artery Stenting (CAS) System
4.3.1 Overview
4.3.2 �鶹ԭ�� Sizing (Actual & Forecasted)
4.3.3 �鶹ԭ�� Share by Region
4.4 Stent Retriever �鶹ԭ��
4.4.1 Overview
4.4.2 �鶹ԭ�� Sizing (Actual & Forecasted)
5. Regional Analysis
5.1 North America (The US)
5.1.1 �鶹ԭ�� Sizing (Actual & Forecasted)
5.1.2 �鶹ԭ�� Share by Segment
5.1.3 Cerebral Thrombectomy Devices �鶹ԭ�� Sizing (Actual & Forecasted)
5.1.4 Flow Diverter Devices �鶹ԭ�� Sizing (Actual & Forecasted)
5.1.5 Carotid Artery Stenting (CAS) Systems Devices �鶹ԭ�� Sizing (Actual & Forecasted)
5.2 Europe
5.2.1 �鶹ԭ�� Sizing (Actual & Forecasted)
5.2.2 �鶹ԭ�� Share by Segment
5.2.3 Cerebral Thrombectomy Devices �鶹ԭ�� Sizing (Actual & Forecasted)
5.2.4 Flow Diverter Devices �鶹ԭ�� Sizing (Actual & Forecasted)
5.3 Asia Pacific
5.3.1 �鶹ԭ�� Sizing (Actual & Forecasted)
5.3.2 �鶹ԭ�� Share by Segment
5.3.3 Cerebral Thrombectomy Devices �鶹ԭ�� Sizing (Actual & Forecasted)
6. Global Neurovascular �鶹ԭ�� Dynamics
6.1 Industry Trends & Developments
6.1.1 Mergers & Acquisitions
6.1.2 Technological Advancement
6.1.3 Advent of ARTS (Aspiration-Retriever Technique for Stroke)
6.2 Growth Drivers
6.2.1 Rising Prevalence of Cerebrovascular disease
6.2.2 Higher Incidences of Neurological Disorders
6.2.3 Favorable Reimbursement Policies
6.2.4 Expanding Healthcare Infrastructure
6.3 Challenges
6.3.1 High Cost of Treatment
6.3.2 Multiple Product Recalls
6.3.3 Dearth of Skilled Neurosurgeons
6.3.4 Social Stigma
7. Competitive Landscape
7.1 Global
7.2 Regional
8. Company Profiles
8.1 Johnson & Johnson DePuy Synthes
8.2 Stryker Corporation
8.3 Medtronic Plc.
8.4 Penumbra Inc.
8.5 Terumo Corporation

List of Tables
Table 1: Classification of Neurological Medical Devices
Table 2: Major Neurovascular Products
Table 3: New Generation Cerebral Thrombectomy Devices
Table 4: Flow Diverter Devices
Table 5: Mergers & Acquisitions in Neurovascular Intervention �鶹ԭ��
Table 6: Number of Disability-Adjusted Life Years (DALYs) for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 And 2030 (Thousands)
Table 7: Deaths Attributable to Neurological Disorders as Percentage of Total Deaths, 2005, 2015 And 2030
Table 8: Major Neurovascular Companies – Competitive Landscape

List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Global Neurovascular Intervention �鶹ԭ�� Size by Value, 2008-18E (US$ Millions)
Figure 3: Global Neurovascular Intervention �鶹ԭ�� Size by Value Forecasted, 2019E-24E (US$ Billions)
Figure 4: Global Therapeutic Neurovascular Intervention Device �鶹ԭ�� Share by Region (2018E)
Figure 5: Global Neurovascular Intervention �鶹ԭ�� Share by Therapeutic Application (2018E)
Figure 6: Global Neurovascular Intervention �鶹ԭ�� Share by Technique (2018E)
Figure 7: Global Cerebral Thrombectomy Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 8: Global Cerebral Thrombectomy Devices �鶹ԭ�� Share by Region (2018E)
Figure 9: Global Flow Diverting Aneurysm Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 10: Global Flow Diversion �鶹ԭ�� Share by Region (2018E)
Figure 11: Global Carotid Artery Stenting (CAS) System �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 12: Global Carotid Artery Stenting (CAS) Systems Devices �鶹ԭ�� Share by Region (2018E)
Figure 13: Neurovascular Stent Retriever �鶹ԭ�� Size by Value, 2016-24E (US$ Millions)
Figure 14: The US Neurovascular Intervention Systems �鶹ԭ�� Size by Value, 2013-24E (US$ Billions)
Figure 15: The US Neurovascular Intervention Systems �鶹ԭ�� Share by Segment (2018E)
Figure 16: The US Cerebral Thrombectomy Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 17: The US Flow Diverter Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 18: The US Carotid Artery Stenting (CAS) Systems Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 19: Europe Neurovascular Intervention Systems �鶹ԭ�� Size by Value, 2013-24E (US$ Billions)
Figure 20: Europe Neurovascular Intervention Systems �鶹ԭ�� Share by Segment (2018E)
Figure 21: Europe Cerebral Thrombectomy Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 22: Europe Flow Diverter Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 23: Asia Pacific Neurovascular Intervention Systems �鶹ԭ�� Size by Value, 2013-24E (US$ Billions)
Figure 25: Asia Pacific Neurovascular Intervention Systems �鶹ԭ�� Share by Segment (2018E)
Figure 26: Asia Pacific Cerebral Thrombectomy Devices �鶹ԭ�� Size by Value, 2013-24E (US$ Millions)
Figure 27: Global Cerebrovascular Disease Prevalence, 2010-18E (Millions)
Figure 28: Global Healthcare Expenditure, 2012-18E (US$ Trillions)
Figure 29: Global Neurovascular Intervention �鶹ԭ�� Share by Competitors (2018E)
Figure 30: Global Carotid Artery Stenting (CAS) �鶹ԭ�� Share by Competitors (2018E)
Figure 31: The US Cerebral Thrombectomy Devices �鶹ԭ�� Share by Companies (2018E)
Figure 32: The US Stent Retriever �鶹ԭ�� Share by Companies (2018E)
Figure 33: Europe Stent Retriever �鶹ԭ�� Share by Companies (2018E)
Figure 34: Johnson & Johnson Revenue by Business Segment (FY2018E)
Figure 35: Johnson & Johnson Net Sales, FY2012-FY2017 (US$ Billions)
Figure 36: Stryker Corporation Revenue by Business Segment (FY2018E)
Figure 37: Stryker Corporation Net Sales, FY2012-FY2017 (US$ Billions)
Figure 38: Medtronic Plc. Revenue by Business Segment (FY2018E)
Figure 39: Medtronic Plc. Net Sales, FY2012-FY2017 (US$ Billions)
Figure 40: Penumbra Inc. Revenue by Business Segment (FY2018E)
Figure 41: Penumbra Inc.Net Sales, FY2012-FY2017 (US$ Billions)
Figure 42: Terumo Corporation Revenue by Business Segment (FY2018E)
Figure 43: Terumo Corporation Net Sales, FY2012-FY2017 (US$ Billions)